Physician profile
Meagan Tibbo
NPI 1003270687
$17,893.65
in general payments reported to CMS, 2019-2025
15 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,026 · 2021: $5,926 · 2022: $7,080 · 2023: $1,444 · 2024: $960 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,862.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,426.97 | 2021-2024 | Real Intelligence, Evos, Journey II |
| Stryker Corporation | $2,317.44 | 2019-2025 | Mako, Serrato, Gmrs |
| Encore Medical, LP | $1,625.97 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,526.32 | 2019-2021 | |
| Illuminoss Medical, INC. | $478.27 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Depuy Synthes Sales INC. | $270.74 | 2019-2024 | Actis, Emphasys, Velys |
| Onkos Surgical, INC. | $255.96 | 2022-2023 | Eleos Limb Salvage System |
| Acumed LLC | $185.37 | 2024 | Acumed |
| Restor3d, INC. | $177.31 | 2025 | |
| Biocomposites INC | $157.36 | 2019-2024 | |
| Medtronic, INC. | $133.18 | 2022 | |
| Total Joint Orthopedics, INC. | $119.43 | 2019 | |
| Linkbio Corp | $97.16 | 2023 | |
| Pacira Therapeutics, INC. | $66.01 | 2021 | |
| Zimmer Biomet Holdings, INC. | $56.16 | 2022-2023 | Rosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Tibbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.